RemeGen Forecast, price target & analysts
CN¥95.66
12.67%
Hong Kong, Nov 04, 03:00 pm HKT.
Closed.
Why the stock moved Beta
ISIN
CNE1000048G6
Symbol
9995
Industry
RemeGen Target price 2026 - Analyst rating & recommendation
Powered by
RemeGen Classifications & Recommendation
Buy
82%
Hold
18%
RemeGen Price Target
| Target Price | CN¥84.91 |
| Price | CN¥95.66 |
| Deviation | |
| Number of Estimates | 8 |
| 8 Analysts have issued a price target RemeGen 2027 . The average RemeGen target price is CN¥84.91. This is lower than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 11 analysts: 9 Analysts recommend RemeGen to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the RemeGen stock has an average upside potential 2027 of . Most analysts recommend the RemeGen stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CN¥ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? |
11 Analysts have issued a sales forecast RemeGen 2026 . The average RemeGen sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CN¥ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
